Search Results - "Bagust, A"

Adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis: a systematic review and economic evaluation by McLeod, C, Bagust, A, Boland, A, Dagenais, P, Dickson, R, Dundar, Y, Hill, R A, Jones, A, Mujica Mota, R, Walley, T

“…To assess the comparative clinical effectiveness and cost-effectiveness of adalimumab, etanercept and infliximab for the treatment of ankylosing spondylitis…”
Get full text

Deteriorating beta‐cell function in type 2 diabetes: a long‐term model by Bagust, A., Beale, S.

“…Background: Type 2 diabetes is characterized by insulin resistance and the progressive loss of islet beta‐cell function. Although the former is already…”
Get full text

The clinical effectiveness and cost-effectiveness of testing for cytochrome P450 polymorphisms in patients with schizophrenia treated with antipsychotics: a systematic review and economic evaluation by Fleeman, N, McLeod, C, Bagust, A, Beale, S, Boland, A, Dundar, Y, Jorgensen, A, Payne, K, Pirmohamed, M, Pushpakom, S, Walley, T, de Warren-Penny, P, Dickson, R

“…To determine whether testing for cytochrome P450 (CYP) polymorphisms in adults entering antipsychotic treatment for schizophrenia leads to improvement in…”
Get full text

Dynamics of bed use in accommodating emergency admissions: stochastic simulation model by Bagust, Adrian, Place, Michael, Posnett, John W

“…Abstract Objective: To examine the daily bed requirements arising from the flow of emergency admissions to an acute hospital, to identify the implications of…”
Get full text

Gefitinib for the first-line treatment of locally advanced or metastatic non-small cell lung cancer by Brown, T, Boland, A, Bagust, A, Oyee, J, Hockenhull, J, Dundar, Y, Dickson, R, Ramani, V S, Proudlove, C

“…This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of gefitinib for the first-line…”
Get full text

Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis by Greenhalgh, J, Bagust, A, Boland, A, Martin Saborido, C, Oyee, J, Blundell, M, Dundar, Y, Dickson, R, Proudlove, C, Fisher, M

“…Occlusive vascular events such as myocardial infarction (MI), ischaemic stroke and transient ischaemic attack (TIA) are the result of a reduction in blood flow…”
Get full text

The projected health care burden of Type 2 diabetes in the UK from 2000 to 2060 by Bagust, A., Hopkinson, P. K., Maslove, L., Currie, C. J.

“…Aims/hypothesis To predict the incidence and prevalence of Type 2 diabetes in the UK, the trends in the levels of diabetes‐related complications, and the…”
Get full text

Lapatinib and trastuzumab in combination with an aromatase inhibitor for the first-line treatment of metastatic hormone receptor-positive breast cancer which over-expresses human epidermal growth factor 2 (HER2): a systematic review and economic analysis by Fleeman, N, Bagust, A, Boland, A, Dickson, R, Dundar, Y, Moonan, M, Oyee, J, Blundell, M, Davis, H, Armstrong, A, Thorp, N

“…Breast cancer is the uncontrolled, abnormal growth of malignant breast tissue affecting predominantly women. Metastatic breast cancer (mBC) is an advanced…”
Get full text

The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation by Hockenhull, J C, Dwan, K, Boland, A, Smith, G, Bagust, A, Dündar, Y, Gamble, C, McLeod, C, Walley, T, Dickson, R

“…To assess the clinical effectiveness and cost-effectiveness of central venous catheters (CVCs) treated with anti-infective agents in preventing…”
Get full text

Deferasirox for the treatment of iron overload associated with regular blood transfusions (transfusional haemosiderosis) in patients suffering with chronic anaemia: a systematic review and economic evaluation by McLeod, C, Fleeman, N, Kirkham, J, Bagust, A, Boland, A, Chu, P, Dickson, R, Dundar, Y, Greenhalgh, J, Modell, B, Olujohungbe, A, Telfer, P, Walley, T

“…To assess the clinical effectiveness and cost-effectiveness of deferasirox for the treatment of iron overload associated with regular blood transfusions in…”
Get full text

Drug-eluting stents: a systematic review and economic evaluation by Hill, R, Boland, A, Dickson, R, Dündar, Y, Haycox, A, McLeod, C, Mujica Mota, R, Walley, T, Bagust, A

“…OBJECTIVESTo assess the effectiveness and cost-effectiveness of the use of drug-eluting coronary artery stents in percutaneous coronary intervention (PCI) in…”
Get full text

Pemetrexed for the maintenance treatment of locally advanced or metastatic non-small cell lung cancer by Greenhalgh, J, McLeod, C, Bagust, A, Boland, A, Fleeman, N, Dundar, Y, Oyee, J, Dickson, R, Davis, H, Green, J, McKenna, E, Pearson, M

“…This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of pemetrexed for the…”
Get full text

Newer hypnotic drugs for the short-term management of insomnia: a systematic review and economic evaluation by Dündar, Y, Boland, A, Strobl, J, Dodd, S, Haycox, A, Bagust, A, Bogg, J, Dickson, R, Walley, T

“…To assess the clinical and cost-effectiveness of zaleplon, zolpidem and zopiclone (Z-drugs) compared with benzodiazepines. Electronic databases, reference…”
Get full text

Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy by Saborido, C Martin, Hockenhull, J, Bagust, A, Boland, A, Dickson, R, Todd, D

“…Atrial fibrillation (AF) is a tachyarrhythmia characterised by uncoordinated atrial activation with consequent deterioration of impairment of atrial function…”
Get full text

Coronary artery stents: a rapid systematic review and economic evaluation by Hill, R, Bagust, A, Bakhai, A, Dickson, R, Dündar, Y, Haycox, A, Mujica Mota, R, Reaney, A, Roberts, D, Williamson, P, Walley, T

“…To assess the effectiveness and cost-effectiveness of the use of coronary artery stents in patients with coronary heart disease (CHD). Electronic databases…”
Get full text

Rituximab for the treatment of rheumatoid arthritis by Bagust, A, Boland, A, Hockenhull, J, Fleeman, N, Greenhalgh, J, Dundar, Y, Proudlove, C, Kennedy, T, Moots, R, Williamson, P, Dickson, R

“…This paper presents a summary of the evidence review group's critical review of the evidence for the clinical effectiveness and cost-effectiveness of rituximab…”
Get full text

Cetuximab for the treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck by Greenhalgh, J, Bagust, A, Boland, A, Fleeman, N, McLeod, C, Dundar, Y, Proudlove, C, Shaw, R

“…This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of cetuximab for recurrent…”
Get full text

Corrigendum: Clinical effectiveness and cost-effectiveness of first-line chemotherapy for adult patients with locally advanced or metastatic non-small cell lung cancer: a systematic review and economic evaluation by Brown, T, Pilkington, G, Bagust, A, Boland, A, Oyee, J, Tudur Smith, C, Blundell, M, Lai, M, Martin Saborido, C, Greenhalgh, J, Dundar, Y, Dickson, R

“…Abstract Table 96 has been removed as it includes incorrect hazard ratios caused by a reversal of the hazard ratio calculations. However, this does not impact…”
Get full text

The clinical effectiveness and cost-effectiveness of computed tomography screening for lung cancer: systematic reviews by Black, C, Bagust, A, Boland, A, Walker, S, McLeod, C, De Verteuil, R, Ayres, J, Bain, L, Thomas, S, Godden, D, Waugh, N

“…The aim of this review is to examine the clinical and cost-effectiveness of screening for lung cancer using computed tomography (CT) to assist policy making…”
Get full text

Pemetrexed for the first-line treatment of locally advanced or metastatic non-small cell lung cancer by Fleeman, N, Bagust, A, McLeod, C, Greenhalgh, J, Boland, A, Dundar, Y, Dickson, R, Tudur Smith, C, Davis, H, Green, J, Pearson, M

“…This paper presents a summary of the evidence review group (ERG) report into the clinical effectiveness and cost-effectiveness of pemetrexed for the first-line…”
Get full text